Study Finds Gene Variants Affect Common Drug Response

University of Pittsburgh researchers analyzed nearly 100,000 genomes to map how genetic variants may change how people respond to medications.

Updated on Nov. 11, 2026 in Science

Bold vector editorial illustration of cream capsules beside a coiled teal strand on a slate-blue field, evoking genetic research on drug response.
Researchers at the University of Pittsburgh analyzed nearly 100,000 genomes and found every participant carried a variant that could alter how they respond to medications. AI Illustration. Upload story photo >

Live Poll

Would you want your doctor to test your genes before prescribing medication?

University of Pittsburgh researchers analyzed the whole genome sequences and health records of nearly 100,000 All of Us Research Program participants. The study found that every participant carried at least one genetic variant relevant to medication response.

Why it matters

Pharmacogenomic data has been limited by small population datasets and by most genetic research focusing on people of European ancestry. Broader data could help clinicians tailor medication choices and doses for more patients.

The analysis drew on whole genome sequences and health records of nearly 100,000 participants, with about 99.5% carrying a variant tied to FDA or guideline dosing recommendations. Computer models predict that roughly a quarter of the 17,704 newly identified variants may significantly affect drug processing, a finding that still awaits clinical validation.

The players

University of Pittsburgh

A public research university in Pittsburgh, Pennsylvania, whose researchers conducted the analysis of drug-gene variants.

All of Us Research Program

A large U.S. National Institutes of Health initiative that collects genomic and health data from participants across the country to advance precision medicine.

The details

Researchers paired genome sequence data with electronic health records to identify drugs participants had already taken, examining 16 genes with established links to medication response. Common affected drugs included omeprazole, pantoprazole, and statins, and the study reported variant frequencies for genetic ancestries with previously incomplete data.

Timeline

  1. November 11, 2026: Study results were published and the article released.

Life Sciences Context

The findings build on the All of Us Research Program's effort to diversify genomic data beyond people of European ancestry, which has long limited pharmacogenomic research. Expanding that dataset could allow future prescribing guidelines to account for variants that current recommendations miss.

Pharmacogenomic findings like these could eventually help clinicians choose medications and doses that fit a patient's genetic profile, potentially reducing trial-and-error prescribing. The research is still early, and no change to current prescribing is established by this study alone.

The takeaway

Your genes may influence how well common medications work for you, so ask your clinician whether pharmacogenomic testing is appropriate if you take drugs like statins or acid reducers regularly. Discuss any concerns before changing a prescription.

Further reading

For related context, explore more Life Sciences coverage on how genetics shape medical care.

Live Poll

Would you want your doctor to test your genes before prescribing medication?